CD26 is a biomarker that can enhance response to T cell therapy in advanced melanoma Shannon K. Swisher,Megan M. Wyatt,Megen C. Wittling,Ayana T. Ruffin,Keith A. Delman,Gregory B. Lesinski,Michael C. Lowe, Clnystal M. PaulosANNALS OF SURGICAL ONCOLOGY（2024）引用 0|浏览20AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
